ClearVue (ASX:CPV) raises A$6m to fund an AI data centre pivot

Doug Hunt is pointing the next product generation at cooling-stressed AI infrastructure, which reframes the BIPV story

ClearVue Technologies (ASX:CPV) has raised A$6 million across a A$5 million placement and a A$1 million underwritten share purchase plan, priced at A$0.115. That is a 14.3% discount to the 30-day VWAP of A$0.1342, with one free attaching option per share at the same strike over three years.

On the headline math, the raise lifts shares on issue from roughly 307 million to around 359 million, a base dilution of about 14% before the attaching options come into play. The placement was supported by institutional, sophisticated and professional investors.

But the more interesting part is not the structure. It is the strategic pivot CEO Doug Hunt signposted in his commentary. ClearVue is now openly aiming a new generation of high-performance insulated building materials at the AI data centre buildout.

That is a meaningful repositioning for a company most investors still think of as a solar window business. Following the Canva HQ install and last year’s Gen3 Solar Vision Glass validation showing a 66% output uplift, today’s raise looks designed to fund the jump from referenceable projects into a much larger end market.

The dilution is real, but the option overhang is the bigger question

At A$0.115, the placement clears at a 14.3% discount to the 30-day VWAP. That is on the wider end for a clean balance-sheet top-up but not unusual for a microcap selling growth capital into a soft tape.

The real overhang sits in the attaching options. Including the SPP and lead manager options, we count roughly 65 million options struck at A$0.115 with a three-year window. If exercised in full, that functions as a second raise at the same price.

Our concern is that this option load caps the upside near A$0.115 until they either expire worthless or get converted. Investors buying today need to model the fully diluted share count, not the headline placement number.

The AI data centre angle is the part the market has not priced

Hunt’s commentary spends as much time on insulated building materials for data centres as it does on the core solar glass platform. The pitch is that AI training infrastructure is forcing operators to attack cooling loads and lifecycle energy costs through the building envelope itself.

We think this is a credible adjacent market, because the underlying materials science around coatings and thermal management is the same toolkit ClearVue uses for BIPV. The Canva install proved the company can do bespoke envelope engineering at commercial scale.

The skeptical read is that data centre operators have tight approved-vendor lists and notoriously long qualification cycles. A pivot announcement is not a contract, and the raise needs to fund a credible certification pathway before this angle moves the share price.

Where the A$6m actually goes tells you the life-cycle stage

The use of funds list is heavy on operational scaffolding rather than product launches. ERP implementation, product certification, patent maintenance, marketing and international business development sit ahead of pure R&D.

Worth noting that the announcement explicitly mentions strengthening the balance sheet to meet customer, partner and investor due diligence requirements. Translation, the deals on the table have grown to the point where counterparty credit checks are now a real gate.

The Investors Takeaway for ClearVue Technologies

The next 12 months are about converting pipeline into signed contracts while a meaningful option overhang sits at A$0.115. The Canva referenceability, the Gen3 economics and now the data centre angle give ClearVue three distinct shots on goal, which is more optionality than most cleantech microcaps carry into a raise.

We would want to see at least one signed data centre or major corporate envelope deal land before the attaching options come into the money in any sustained way. Investors can read our previous coverage of the Canva HQ win at stocksdownunder, which sets the context for why this raise is funding execution rather than science.